HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-MAY-13 4KSQ TITLE CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR 5B COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 445-726; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1, P94; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS HUMAN SERINE/THERONINE PROTEIN KINASE, KINASE DRUG COMPLEX, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.K.YANO,O.MASANORI REVDAT 4 28-FEB-24 4KSQ 1 REMARK SEQADV REVDAT 3 15-NOV-17 4KSQ 1 REMARK REVDAT 2 04-SEP-13 4KSQ 1 JRNL REVDAT 1 24-JUL-13 4KSQ 0 JRNL AUTH M.OKANIWA,M.HIROSE,T.ARITA,M.YABUKI,A.NAKAMURA,T.TAKAGI, JRNL AUTH 2 T.KAWAMOTO,N.UCHIYAMA,A.SUMITA,S.TSUTSUMI,T.TOTTORI,Y.INUI, JRNL AUTH 3 B.C.SANG,J.YANO,K.AERTGEERTS,S.YOSHIDA,T.ISHIKAWA JRNL TITL DISCOVERY OF A SELECTIVE KINASE INHIBITOR (TAK-632) JRNL TITL 2 TARGETING PAN-RAF INHIBITION: DESIGN, SYNTHESIS, AND JRNL TITL 3 BIOLOGICAL EVALUATION OF C-7-SUBSTITUTED 1,3-BENZOTHIAZOLE JRNL TITL 4 DERIVATIVES. JRNL REF J.MED.CHEM. V. 56 6478 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23906342 JRNL DOI 10.1021/JM400778D REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 14103 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 720 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.39 REMARK 3 REFLECTION IN BIN (WORKING SET) : 963 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.61 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4093 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.00000 REMARK 3 B22 (A**2) : -1.00000 REMARK 3 B33 (A**2) : 1.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.481 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.354 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 48.885 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4267 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4108 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5771 ; 1.132 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9443 ; 0.692 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 509 ; 5.627 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;35.171 ;23.859 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 766 ;17.663 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;18.435 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 626 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4755 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 965 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 447 A 532 REMARK 3 ORIGIN FOR THE GROUP (A): 48.7258 -31.0145 13.1750 REMARK 3 T TENSOR REMARK 3 T11: 0.1612 T22: 0.2504 REMARK 3 T33: 0.3164 T12: 0.0441 REMARK 3 T13: 0.0239 T23: 0.1109 REMARK 3 L TENSOR REMARK 3 L11: 4.2073 L22: 2.8875 REMARK 3 L33: 7.3818 L12: 0.7895 REMARK 3 L13: 2.2681 L23: 0.3753 REMARK 3 S TENSOR REMARK 3 S11: -0.0722 S12: -0.6364 S13: -0.3420 REMARK 3 S21: 0.2250 S22: -0.1451 S23: -0.8278 REMARK 3 S31: 0.1592 S32: 0.6046 S33: 0.2173 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 533 A 721 REMARK 3 ORIGIN FOR THE GROUP (A): 43.3556 -43.3099 -9.5136 REMARK 3 T TENSOR REMARK 3 T11: 0.1188 T22: 0.1590 REMARK 3 T33: 0.0429 T12: -0.0253 REMARK 3 T13: -0.0062 T23: -0.0073 REMARK 3 L TENSOR REMARK 3 L11: 1.3360 L22: 4.7522 REMARK 3 L33: 2.4277 L12: -0.9511 REMARK 3 L13: -1.6857 L23: 1.0401 REMARK 3 S TENSOR REMARK 3 S11: 0.0913 S12: 0.1621 S13: 0.0822 REMARK 3 S21: -0.2555 S22: 0.0293 S23: -0.0200 REMARK 3 S31: -0.1986 S32: -0.0194 S33: -0.1206 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 448 B 532 REMARK 3 ORIGIN FOR THE GROUP (A): 35.8602 -12.3685 -2.8111 REMARK 3 T TENSOR REMARK 3 T11: 0.3023 T22: 0.1029 REMARK 3 T33: 0.3561 T12: 0.1007 REMARK 3 T13: 0.0127 T23: 0.0637 REMARK 3 L TENSOR REMARK 3 L11: 2.2459 L22: 5.5210 REMARK 3 L33: 4.5062 L12: -0.1543 REMARK 3 L13: -0.4582 L23: -0.6112 REMARK 3 S TENSOR REMARK 3 S11: 0.0845 S12: 0.3234 S13: 0.7758 REMARK 3 S21: -0.5527 S22: -0.3156 S23: 0.0282 REMARK 3 S31: -0.6865 S32: -0.3293 S33: 0.2311 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 533 B 719 REMARK 3 RESIDUE RANGE : B 901 B 901 REMARK 3 ORIGIN FOR THE GROUP (A): 20.7970 -15.7815 18.3310 REMARK 3 T TENSOR REMARK 3 T11: 0.0907 T22: 0.0259 REMARK 3 T33: 0.0710 T12: -0.0150 REMARK 3 T13: 0.0326 T23: 0.0088 REMARK 3 L TENSOR REMARK 3 L11: 3.8080 L22: 2.3052 REMARK 3 L33: 2.2482 L12: -1.3974 REMARK 3 L13: -0.9792 L23: 1.6213 REMARK 3 S TENSOR REMARK 3 S11: 0.1058 S12: 0.0485 S13: -0.0556 REMARK 3 S21: 0.2169 S22: -0.0900 S23: -0.0976 REMARK 3 S31: 0.0962 S32: 0.0281 S33: -0.0158 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 4KSQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-13. REMARK 100 THE DEPOSITION ID IS D_1000079747. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : SINGLE SI(220) CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14150 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.26300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.86000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.8% PEG 8000, 0.8M LICL, 100 MM TRIS REMARK 280 PH 8.3, SITTING DROP, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.28950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.41450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.41450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.14475 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.41450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.41450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 108.43425 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.41450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.41450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.14475 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.41450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.41450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 108.43425 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.28950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 442 REMARK 465 SER A 443 REMARK 465 ASP A 444 REMARK 465 SER A 445 REMARK 465 SER A 446 REMARK 465 ALA A 597 REMARK 465 THR A 598 REMARK 465 VAL A 599 REMARK 465 LYS A 600 REMARK 465 SER A 601 REMARK 465 ARG A 602 REMARK 465 TRP A 603 REMARK 465 SER A 604 REMARK 465 GLY A 605 REMARK 465 SER A 606 REMARK 465 HIS A 607 REMARK 465 GLN A 608 REMARK 465 PHE A 609 REMARK 465 GLU A 610 REMARK 465 GLN A 611 REMARK 465 LEU A 612 REMARK 465 SER A 613 REMARK 465 LYS A 722 REMARK 465 ILE A 723 REMARK 465 HIS A 724 REMARK 465 ARG A 725 REMARK 465 GLY B 442 REMARK 465 SER B 443 REMARK 465 ASP B 444 REMARK 465 SER B 445 REMARK 465 SER B 446 REMARK 465 ASP B 447 REMARK 465 ALA B 597 REMARK 465 THR B 598 REMARK 465 VAL B 599 REMARK 465 LYS B 600 REMARK 465 SER B 601 REMARK 465 ARG B 602 REMARK 465 TRP B 603 REMARK 465 SER B 604 REMARK 465 GLY B 605 REMARK 465 SER B 606 REMARK 465 HIS B 607 REMARK 465 GLN B 608 REMARK 465 PHE B 609 REMARK 465 GLU B 610 REMARK 465 GLN B 611 REMARK 465 LEU B 612 REMARK 465 SER B 613 REMARK 465 LEU B 720 REMARK 465 PRO B 721 REMARK 465 LYS B 722 REMARK 465 ILE B 723 REMARK 465 HIS B 724 REMARK 465 ARG B 725 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 521 CG CD CE NZ REMARK 470 PHE B 467 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 521 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 485 48.18 -97.66 REMARK 500 ARG A 574 -17.09 74.68 REMARK 500 ASP A 575 50.33 -151.51 REMARK 500 LEU A 583 79.51 -101.86 REMARK 500 ASP A 586 19.93 52.15 REMARK 500 LEU A 587 -54.61 -136.51 REMARK 500 MET A 626 58.85 38.79 REMARK 500 ASP A 628 -153.35 -100.19 REMARK 500 PHE B 467 -78.77 -69.67 REMARK 500 ASN B 485 67.34 -100.82 REMARK 500 ARG B 508 87.97 -154.09 REMARK 500 ILE B 542 -76.41 -107.01 REMARK 500 ASP B 575 52.21 -166.99 REMARK 500 GLU B 585 25.73 48.92 REMARK 500 LEU B 587 -29.61 -149.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1SW A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1SW B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DBN RELATED DB: PDB REMARK 900 B-RAF INHIBITOR REMARK 900 RELATED ID: 3Q96 RELATED DB: PDB REMARK 900 B-RAF INHIBITOR REMARK 900 RELATED ID: 4KSP RELATED DB: PDB REMARK 900 B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632 DBREF 4KSQ A 444 725 UNP P15056 BRAF_HUMAN 445 726 DBREF 4KSQ B 444 725 UNP P15056 BRAF_HUMAN 445 726 SEQADV 4KSQ GLY A 442 UNP P15056 EXPRESSION TAG SEQADV 4KSQ SER A 443 UNP P15056 EXPRESSION TAG SEQADV 4KSQ GLY B 442 UNP P15056 EXPRESSION TAG SEQADV 4KSQ SER B 443 UNP P15056 EXPRESSION TAG SEQRES 1 A 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 A 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 A 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 A 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 A 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 A 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 B 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 B 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 B 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 B 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 B 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG HET 1SW A 901 39 HET 1SW B 901 39 HETNAM 1SW N-{7-CYANO-6-[4-FLUORO-3-({[3-(TRIFLUOROMETHYL) HETNAM 2 1SW PHENYL]CARBAMOYL}AMINO)PHENOXY]-1,3-BENZOTHIAZOL-2- HETNAM 3 1SW YL}CYCLOPROPANECARBOXAMIDE FORMUL 3 1SW 2(C26 H17 F4 N5 O3 S) HELIX 1 1 THR A 490 ARG A 505 1 16 HELIX 2 2 SER A 535 ILE A 542 1 8 HELIX 3 3 GLU A 548 LYS A 569 1 22 HELIX 4 4 LYS A 577 ASN A 579 5 3 HELIX 5 5 GLU A 585 LEU A 587 5 3 HELIX 6 6 SER A 615 MET A 619 5 5 HELIX 7 7 ALA A 620 ARG A 625 1 6 HELIX 8 8 SER A 633 GLY A 651 1 19 HELIX 9 9 ASN A 660 GLY A 671 1 12 HELIX 10 10 ASP A 676 VAL A 680 5 5 HELIX 11 11 PRO A 685 LEU A 696 1 12 HELIX 12 12 LYS A 699 ARG A 703 5 5 HELIX 13 13 LEU A 705 SER A 719 1 15 HELIX 14 14 THR B 490 ARG B 505 1 16 HELIX 15 15 LEU B 536 ILE B 542 1 7 HELIX 16 16 GLU B 548 LYS B 569 1 22 HELIX 17 17 LYS B 577 ASN B 579 5 3 HELIX 18 18 SER B 615 MET B 619 5 5 HELIX 19 19 ALA B 620 MET B 626 1 7 HELIX 20 20 SER B 633 GLY B 651 1 19 HELIX 21 21 ASN B 660 GLY B 671 1 12 HELIX 22 22 ASP B 676 VAL B 680 5 5 HELIX 23 23 PRO B 685 LEU B 696 1 12 HELIX 24 24 LYS B 699 ARG B 703 5 5 HELIX 25 25 LEU B 705 ARG B 718 1 14 SHEET 1 A 5 THR A 457 GLY A 465 0 SHEET 2 A 5 GLY A 468 LYS A 474 -1 O LYS A 472 N GLY A 459 SHEET 3 A 5 ASP A 478 MET A 483 -1 O MET A 483 N THR A 469 SHEET 4 A 5 ALA A 525 GLN A 529 -1 O THR A 528 N ALA A 480 SHEET 5 A 5 PHE A 515 SER A 519 -1 N GLY A 517 O VAL A 527 SHEET 1 B 2 ILE A 581 HIS A 584 0 SHEET 2 B 2 THR A 588 ILE A 591 -1 O LYS A 590 N PHE A 582 SHEET 1 C 5 THR B 457 SER B 464 0 SHEET 2 C 5 THR B 469 LYS B 474 -1 O VAL B 470 N GLY B 463 SHEET 3 C 5 ASP B 478 MET B 483 -1 O VAL B 479 N GLY B 473 SHEET 4 C 5 ALA B 525 GLN B 529 -1 O ILE B 526 N LYS B 482 SHEET 5 C 5 PHE B 515 SER B 519 -1 N GLY B 517 O VAL B 527 SHEET 1 D 3 GLY B 533 SER B 535 0 SHEET 2 D 3 ILE B 581 HIS B 584 -1 O LEU B 583 N SER B 534 SHEET 3 D 3 THR B 588 ILE B 591 -1 N THR B 588 O HIS B 584 CISPEP 1 LYS A 521 PRO A 522 0 -0.66 CISPEP 2 LYS B 521 PRO B 522 0 -2.03 SITE 1 AC1 17 ALA A 480 LYS A 482 GLU A 500 LEU A 504 SITE 2 AC1 17 LEU A 513 ILE A 526 THR A 528 GLN A 529 SITE 3 AC1 17 TRP A 530 CYS A 531 GLY A 533 HIS A 573 SITE 4 AC1 17 PHE A 582 ILE A 591 GLY A 592 ASP A 593 SITE 5 AC1 17 PHE A 594 SITE 1 AC2 19 ALA B 480 LYS B 482 GLU B 500 LEU B 504 SITE 2 AC2 19 ILE B 512 LEU B 513 ILE B 526 THR B 528 SITE 3 AC2 19 GLN B 529 TRP B 530 CYS B 531 GLY B 533 SITE 4 AC2 19 LEU B 566 HIS B 573 PHE B 582 ILE B 591 SITE 5 AC2 19 GLY B 592 ASP B 593 PHE B 594 CRYST1 110.829 110.829 144.579 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009023 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009023 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006917 0.00000